FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

423 letters match. Newest first.

  1. Moorish Science Temple, The Divine and National Movement of North America, Inc; #13 The Moorish American National Republic dba Moor Herbs, Inc.

    FDA warned Moor Herbs that its herbal products are unapproved drugs with disease claims and are made without required supplement quality controls.

    High risk
  2. Natural Ophthalmics, Inc.

    FDA warned Natural Ophthalmics that six eye drop products are unapproved new drugs sold without FDA approval.

    High risk
  3. Tesla BioHealing, Inc.

    FDA warns Tesla BioHealing over unapproved MedBed and BioHealer devices marketed for serious diseases.

    High risk
  4. Molluscumaway LLC

    FDA warned Molluscumaway LLC that its molluscum patches, ointment, and body wash are unapproved new drugs.

    High risk
  5. Nature’s Innovation, Inc.

    FDA warned Nature’s Innovation over unapproved drugs marketed for molluscum and shingles, including a kit for children.

    High risk
  6. Thrasio, LLC D/B/A ZymaDerm

    FDA warned Thrasio/ZymaDerm that its ZymaDerm for Molluscum is an unapproved new drug marketed without FDA approval.

    High risk
  7. Amazon.com, Inc

    FDA warned Amazon that it sold four unapproved drugs claiming to treat molluscum contagiosum, including products marketed for children.

    High risk
  8. King Systems Corp. dba Ambu, Inc.

    FDA warns Ambu's King Systems over unapproved King LTS-D airway device and pediatric website claims.

    High risk
  9. Source-Omega LLC

    Source-Omega LLC's algae omega-3 oils are unapproved new drugs and misbranded because website claims say they treat or prevent disease.

    Low
  10. Hekma Center, LLC

    FDA says Hekma Center sold dietary supplements with claims to treat serious diseases, making them unapproved new drugs.

    High risk
  11. STPCA Inc. dba Sun Ten Laboratories

    FDA: Sun Ten Laboratories sold herbal products as unapproved drugs and broke supplement manufacturing rules at its Irvine, California plant.

    High risk
  12. Gadget Island, Inc.

    Gadget Island sold three male enhancement products containing undeclared tadalafil and sildenafil without FDA approval.

    High risk
  13. Five Leaf Pet Botanicals, Inc.

    Five Leaf Pet Botanicals marketed unapproved animal drugs for dogs with disease-treatment claims on its websites.

    Medium
  14. Outset Medical, Inc.

    FDA warns Outset Medical over unapproved TabloCart and promotion of Tablo dialysis system for unapproved CRRT use.

    High risk
  15. Sunshine Trading Company, Inc. dba Nova Tea and Nova Kratom

    FDA warned Nova Kratom that its kratom products are unapproved new drugs marketed to treat opioid addiction and withdrawal.

    High risk
  16. ZYTO Technologies, Inc.

    FDA warns ZYTO over unapproved disease claims for Hand Cradle GSR and quality-system failures.

    High risk
  17. North Carolina Hemp Exchange, LLC dba NC Hemp Shoppe

    FDA and FTC warn NC Hemp Shoppe over Delta-8 THC edibles with unsafe additive and child-appealing copycat packaging.

    High risk
  18. Warrior Labz SARMS

    FDA warned Warrior Labz SARMS that it sells unapproved new drugs, including SARMs and injectables, with drug claims online.

    High risk
  19. Vitang Technology LLC

    Vitang Technology sold dental aligners designed with uncleared software without a new 510(k) and with quality system failures.

    High risk
  20. A&Z Pharmaceutical, Inc.

    A&Z Pharmaceutical marketed a kids’ calcium supplement with disease claims, making it an unapproved and illegally labeled drug.

    Low
  21. citypharma.us

    FDA warned citypharma.us for selling unapproved, misbranded opioid, benzodiazepine, and stimulant drugs to U.S. consumers online.

    High risk
  22. H.E.A.L. Marketplace

    H.E.A.L. Marketplace sold four herbal products as unapproved new drugs with disease-treatment claims, FDA says.

    High risk
  23. iSlim, LLC

    FDA warned iSlim, LLC that its Alfia Weight Loss Capsules are an unapproved, misbranded drug containing undeclared sibutramine.

    High risk
  24. Sorcerz.com

    FDA warned Sorcerz.com for selling unapproved, misbranded opioid and benzodiazepine drugs to U.S. consumers online.

    High risk
  25. Spartan Enterprises Inc. dba Watershed Wellness Center

    FDA warned Spartan Enterprises/Watershed Wellness that its Dr. Bob’s Naturals supplements are unapproved drugs and are made under CGMP violations.

    High risk
  26. ByPro Nutrition LLC

    FDA warned ByPro Nutrition that its supplement Dodecin is an unapproved and misbranded drug because of pain and disease claims.

    High risk
  27. North American Diagnostics, LLC

    FDA warns North American Diagnostics over unapproved COVID-19 antigen tests and quality system failures.

    High risk
  28. Todos Medical Ltd aka Todos Medical USA Inc

    FDA warned Todos Medical over selling Tollovid as an unapproved COVID-19 drug and misbranded product.

    High risk
  29. Jackson Health & Wellness Clinic

    FDA warned Jackson Health & Wellness Clinic that website claims for Dr. Miller’s teas and supplements make them unapproved and misbranded drugs.

    Low
  30. Organic Heirloom Plants

    FDA warned Organic Heirloom Plants over selling unapproved drugs with claims to treat mpox, cancer, diabetes and other diseases.

    High risk
  31. Dr. Green Mom, LLC

    FDA warned Dr. Green Mom, LLC that its vitamin, zinc, immunity and colloidal silver products are unapproved new drugs because of disease claims on its website.

    High risk
  32. Old Tiles Wallpaper, LLC DBA Old Tiles Decor

    Old Tiles Decor sold three unapproved 'Wind River' remedies online with drug claims, including treating mpox sores, heart problems and flu.

    High risk
  33. Monkeypox-treatment.com

    FDA warned Monkeypox-treatment.com and Eric Sminia for promoting Amazon-linked products as mpox treatments without FDA approval.

    High risk
  34. Medical Mikes, Inc.

    FDA and FTC warned Medical Mikes over unapproved CBD claims to prevent or treat COVID-19.

    High risk
  35. Purecraft LLC

    FDA and FTC warn Purecraft LLC over CBD products marketed with unapproved COVID-19 prevention and treatment claims.

    High risk
  36. PharmaCanna

    FDA and FTC warn PharmaCanna over CBDefense 2000, a cannabinoid product claimed to prevent or treat COVID-19 without approval.

    High risk
  37. Empowered Diagnostics LLC

    Empowered Diagnostics distributed COVID-19 test kits without FDA approval or emergency authorization, and some labeling falsely said they were authorized.

    High risk
  38. Saffron USA LLC

    FDA warned Saffron USA that its tea and blend products are unapproved new drugs because website claims say they treat diseases.

    Low
  39. The Truth Company, LLC

    FDA warned The Truth Company, Kinobody and UMZU that website claims made nine supplements unapproved new drugs and misbranded (improperly labeled).

    Low
  40. Newhere Inc dba CBDFX

    FDA warned CBDFX that CBD added to foods is unsafe and its CBD human and animal products are unapproved drugs.

    High risk
  41. 11-11-11 Brands

    FDA warned 11-11-11 Brands that its Mood33 Hemp Infused Herbal Teas contain added CBD, an unapproved food additive that makes them adulterated.

    High risk
  42. Essential Elements

    FDA says Essential Elements’ CholestAid supplement is an unapproved new drug and misbranded because website claims say it treats cholesterol and heart issues.

    Low
  43. iwi

    FDA warned iwi that its iwi Cholesterol supplement is an unapproved new drug because website claims say it lowers cholesterol.

    High risk
  44. BergaMet North America LLC

    FDA warned BergaMet North America that its Cholesterol Command supplement is an unapproved new drug and misbranded because of disease claims.

    High risk
  45. Chambers' Apothecary

    FDA warned Chambers' Apothecary that website claims make Blood Pressure Support and CoEnzyme Q10 unapproved new drugs.

    Low
  46. Calroy Health Sciences, LLC

    FDA told Calroy Health Sciences that website claims make its Arterosil supplement an unapproved drug for treating disease.

    Low
  47. Anabolic Laboratories Inc

    FDA told Anabolic Laboratories its CoQ10 Ubiquinol Prime and Policosanol Microtabs supplements were unapproved new drugs because website claims promised disease treatment.

    Low
  48. Alternative Health Distribution LLC d/b/a CannaAid

    FDA and FTC warned CannaAid over website claims that CBD/cannabinoid products prevent or treat COVID-19.

    High risk
  49. Latin Foods Market

    Latin Foods Market sold Artri King Reforzado con Ortiga y Omega 3, an unapproved drug with undeclared diclofenac and dexamethasone.

    High risk
  50. Walmart Inc.

    Walmart sold Artri King, a joint supplement containing undeclared diclofenac, making it an unapproved and misbranded new drug.

    High risk